Accurx Scribe and TORTUS both deserve assessment as documentation tools, but neither should be declared the winner from distribution figures or a regulatory label alone. For many GP trainees, the practical choice is the product their practice has authorised. Understanding the differences remains useful for career awareness and practice-level discussions.
This article updates the comparison originally published on 13 April 2026, using public material checked on 27 September 2026. It is published by iatroX and includes iatroX among the complementary tools discussed. The documentation products are assessed separately from clinical reference and professional learning.
What each product offers
Accurx Scribe, checked on 27 September 2026, is powered by Tandem and sits within Accurx's wider patient-communication environment. It describes structured consultation notes and documents, coding, review and saving to EMIS and SystmOne. Its phone-to-computer workflow also allows documentation to be captured on a mobile device and reviewed at a computer.
The April comparison described SNOMED-coded notes, linkage with the original triage request and ephemeral audio processing. Coding remains part of the published offering, but a buyer should confirm the exact triage-context and retention arrangements for its deployment rather than treat that older summary as a current technical specification. Accurx's privacy and security support page, dated 27 August 2026, directs customers to its governance material in the Trust Centre.
TORTUS within Surgery Intellect, checked on 27 September 2026, combines consultation capture with structured documentation, suggested coding and patient, colleague or referral letters. X-on describes filing after clinician review and approval. This is an embedded primary care route, while TORTUS also markets hospital and partner offerings.
The earlier article cited four minutes saved per consultation. X-on's current page still describes an average of four minutes per appointment reported by early users, as checked on 27 September 2026. That is a supplier-reported experience, not a guaranteed saving for every practice or a head-to-head result against Accurx.
The Key Differences
Distribution should be treated as a route to availability, not a league table. The April 2026 version cited Accurx's 98% reach across UK GP practices and 3,500+ practices for TORTUS through X-on. Those statements should not be reused as comparable active-scribe adoption counts.
Accurx's current quotes page, checked on 27 September 2026, uses the different formulation of over 98% of GPs in England. That denominator is not identical to UK practices. TORTUS's current site explicitly includes practices reached through X-on in its organisational reach statement. Partner reach does not establish that every practice has activated and routinely uses Surgery Intellect. The earlier distribution winner declaration is therefore not supported by a like-for-like comparison.
Governance also needs a dated correction. The original comparison described TORTUS as MHRA Class I registered with Class IIa pending. TORTUS now reports UKCA Class IIa certification dated 24 June 2026. The pending description is outdated, but the new status is not proof that every future feature or deployment is covered without further scrutiny.
The earlier claim that TORTUS simply wins governance should also be replaced with a scoped assessment. Accurx publishes governance and compliance requirements, dated 27 August 2026, including review of clinical safety documentation, organisational assessment and data-protection arrangements. Buyers should inspect the exact device, intended use and supporting documents for both products. Neither registration nor certification is a blanket defence in a CQC inspection, complaint or ICB review.
Product focus remains different, but not in the absolute terms used before. Accurx places scribing within a broader communication platform. TORTUS is a clinical AI supplier with direct and embedded routes. Its current public discussion includes clinical decision support and downstream work, so describing its roadmap as entirely scribe-focused is no longer appropriate. These ambitions should still be separated from released functions.
EHR integration should be demonstrated rather than inferred. Accurx explicitly describes one-click saving to EMIS and SystmOne. X-on describes approved filing into the clinical record, with its page identifying the relevant system connections. The earlier suggestion that Accurx may have deeper integration because of its communications infrastructure remains a hypothesis to test, not a verified comparative result.
Pricing: the public information has changed
The April version described both products as practice-level expenditure requiring quotes. Organisational procurement remains the relevant context, but Accurx now publishes a more specific schedule.
As published on the Accurx Scribe pricing page, checked on 27 September 2026, pricing is per patient on the list, per year: £0.50 for lists of 1 to 14,999; £0.47 for 15,000 to 89,999; £0.43 for 90,000 to 799,999; and £0.40 for 800,000 or more. These are not prices per consultation. Buyers should confirm the applicable contract, tax treatment and included services in their quote.
The same page lists unlimited scribes, SNOMED coding, EPR integration, training and support within the package. TORTUS's public hospital offering describes licence, enterprise and outcomes-linked arrangements, while partner pricing uses processed audio hours. Those units should not be directly compared with a registered-patient price or assumed to be the Surgery Intellect practice quote.
A credible cost comparison therefore needs the actual proposed deployment. Neither company can be declared cheaper for a particular practice from these unlike public units alone.
A demonstration that would distinguish the products
Consider a fictional practice with a telephone consultation that leads to an edited referral letter and a task for another member of staff. Ask each supplier to demonstrate the complete authorised workflow, including where the original request appears, how the clinician changes the draft and how filing is confirmed.
Then interrupt the process before completion. Can the clinician tell whether the record was saved? Does a retry risk duplication? Who owns the follow-up task? A polished generated note does not answer those questions.
Use the same fictional material and the same endpoint for both demonstrations. Record review time and work performed by other staff, not only the speed at which the first draft appears. No such comparative test was performed for this update, and no measured winner is being claimed.
Where iatroX Fits
Clinical AI governance remains relevant to GP trainees in daily practice and in learning about NHS informatics for the AKT. The earlier article also described iatroX as MHRA-registered and UKCA-marked. The current iatroX description, checked on 27 September 2026, makes the scope clearer: its UK clinical-reference component is UKCA-marked and registered with the MHRA as Class I, while its question banks and other learning tools are educational products.
That status should not be expanded into a blanket statement that every use is governance-compliant. The relevant question is still the component, intended task and local arrangements. Under its September 2026 specification, free Ask-iatroX supports clinical reference grounded in linked sources, not ambient recording or EHR filing.
A clinician can therefore use an authorised scribe for documentation and a separate de-identified reference question for learning. The fact that both involve AI does not make them substitutes.
Choose the right tool for the task
For a practice already using Accurx, its connected communication and documentation workflow deserves a practical demonstration. For a practice using X-on, Surgery Intellect's location inside that environment may be particularly relevant. For a hospital, the available integrations and implementation arrangements require their own assessment rather than extrapolation from general practice.
For a trainee seeking guidance or revision, iatroX is a different category to consider. The verdict is scenario-specific: choose the documentation system that fits the authorised service workflow, and assess reference and learning tools on the separate work they support. Neither reach figures nor certification labels remove the need to examine the actual product.
Frequently asked questions
Is TORTUS still waiting for Class IIa certification?
No. TORTUS reports UKCA Class IIa certification dated 24 June 2026, replacing the pending description in the April version of this article.
Is Accurx Scribe pricing per consultation?
No. The public schedule checked on 27 September 2026 is per patient on the list, per year, with different list-size bands.
Does using Accurx already mean Scribe is automatically available to a practice?
Not necessarily. The organisation should confirm access, contractual terms, activation and the required governance steps rather than infer availability from use of another Accurx product.